Nutex Health, Inc.Financials
|
|
Historical Financials
DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 | DEC 2020 | DEC 2019 | DEC 2018 | DEC 2017 | DEC 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 875,257,000 | 479,949,000 | 247,646,000 | 219,294,306 | 331,531,311 | 274,029,061 | 1,366,419 | 1,366,996 | 23,166 | - | |
| Cost of Revenue | 430,976,000 | 283,688,000 | 212,872,000 | 203,872,568 | 14,647,045 | 909,780 | 830,443 | 507,640 | 30,481 | - | |
| Gross Profit | 444,281,000 | 196,261,000 | 34,774,000 | 15,421,738 | 179,280,958 | 157,606,159 | 535,976 | 859,356 | -7,315 | - |
Sign up to view full financial statements
Create a free CapEdge account to access balance sheet, cash flow, and complete historical data.
DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 | DEC 2020 | DEC 2019 | DEC 2018 | DEC 2017 | DEC 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin (%) | |||||||||||
| R&D Expense | |||||||||||
| SG&A Expense | |||||||||||
| Total Operating Expenses | |||||||||||
| Operating Income or Loss | |||||||||||
| Operating Margin (%) | |||||||||||
| EBITDA | |||||||||||
| Interest Expense | |||||||||||
| Non-Operating Income/Expense | |||||||||||
| Income Before Tax | |||||||||||
| Income Tax Expense | |||||||||||
| Income from Continuing Ops. | |||||||||||
| Net Income | |||||||||||
| Net Profit Margin (%) | |||||||||||
| Basic EPS | |||||||||||
| Diluted EPS | |||||||||||
| Basic Average Shares | |||||||||||
| Diluted Average Shares |
All numbers in thousands. Financial statements are in beta and sourced from EDGAR XBRL filings. Read the caveats.